Status and phase
Conditions
Treatments
About
To evaluate the efficacy of SPD489 compared to placebo in the treatment of moderate to severe binge eating disorder as measured by the number of binge days per week
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion
Exclusion
Primary purpose
Allocation
Interventional model
Masking
271 participants in 4 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal